Vinflunine/gemcitabine versus carboplatin/gemcitabine as first-line treatment in cisplatin-ineligible patients with advanced urothelial carcinoma: A randomised phase II trial (VINGEM)
2020 ◽
Vol 127
◽
pp. 173-182
◽
Karin Holmsten
◽
Niels Viggo Jensen
◽
Lene Sonne Mouritsen
◽
Erika Jonsson
◽
Camilla Mellnert
◽
...
2005 ◽
Vol 23
(5)
◽
pp. 381-382
2005 ◽
Vol 92
(4)
◽
pp. 645-650
◽
A Ardavanis
◽
D Tryfonopoulos
◽
A Alexopoulos
◽
C Kandylis
◽
G Lainakis
◽
...
2017 ◽
Vol 16
(10)
◽
pp. e2797
K. Holmsten
◽
N.V. Jensen
◽
L. Sonne Mouritsen
◽
M. Agerbæk
◽
M.M. Kempel
◽
...
N.D. Fleming
◽
R.L. Coleman
◽
C.S. Tung
◽
M.F. Munsell
◽
A.K. Sood
2021 ◽
Vol 16
(3)
◽
pp. S503
B. Han
◽
W. Zhang
◽
B. Zhang
◽
Y. Chen
◽
Y. Zhang
◽
...
2007 ◽
Vol 73
(1-2)
◽
pp. 9-20
◽
Craig Underhill
◽
David Goldstein
◽
Vera A. Gorbounova
◽
Mikhail Y. Biakhov
◽
Igor S. Bazin
◽
...
2018 ◽
Vol 23
(8)
◽
pp. 919-927
◽
Goro Nakayama
◽
Ayako Mitsuma
◽
Yuki Sunagawa
◽
Kiyoshi Ishigure
◽
Hiroyuki Yokoyama
◽
...
2005 ◽
Vol 16
(2)
◽
pp. 282-288
◽
M.M. Borner
◽
J. Bernhard
◽
D. Dietrich
◽
R. Popescu
◽
M. Wernli
◽
...
2018 ◽
Vol 38
(6)
◽
pp. 3779-3784
◽
HIROAKI TAKEOKA
◽
KAZUHIKO YAMADA
◽
YOSHIKO NAITO
◽
NORIKAZU MATSUO
◽
HIDENOBU ISHII
◽
...
Close
Export Citation Format
Close
Share Document
Close